Companies Dominating the Liquid Pediatric Landscape
- Johnson & Johnson
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis International AG
- Sanofi S.A.
- Merck & Co., Inc.
- AstraZeneca plc
- Boehringer Ingelheim International GmbH
- Eli Lilly and Company
- AbbVie Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of liquid pediatric is estimated at USD 11.49 billion.
The liquid pediatric market size was valued at USD 10.78 billion in 2024 and is likely to cross USD 28.62 billion by 2037, registering more than 7.8% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of pediatric chronic conditions, rising awareness of pediatric health & medication adherence, and expansion of pediatric clinical research & trials will drive the market growth.
Asia Pacific industry is set to account for largest revenue share of 39% by 2037, impelled by surge in the importance of pediatric healthcare in the region.
The major players in the market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Sanofi S.A., Merck & Co., Inc., and others.
